BioSpace News Archive

The Insight Partners published latest research report on “Ferritin Testing Market Growth Report, Size, Share, Trends & Forecast to 2027 - COVID-19 Impact and Global Analysis By Indication, End User and Geography”, the global market size is projected to reach USD 556.19 million by 2027 from USD 372.05 million in 2019.

Zymo Research, a leading provider of microbiology research tools, has officially launched its Full-Length 16S Sequencing Service, offering researchers high-quality, full-length 16S rRNA gene sequencing for microbiome analysis.

Aitia, the leader in the development and application of Causal AI and “Digital Twins” to discover and develop new drugs, today announced a collaboration with Servier to create new Gemini Digital Twins to help in the fight against Pancreatic Cancer.

Aurinia Pharmaceuticals Inc. announced voting results for its annual general meeting of shareholders held on May 17, 2023.

A new study adds to an emerging, radically new picture of how bacterial cells continually repair faulty sections of their DNA.

AB Science SA (Euronext – FR0010557264 – AB) today summarizes the key messages delivered to an audience of key opinion leaders and decision-makers in the field of ALS research and healthcare policy, during an Panel Discussion at the ALS Drug Development Summit in Boston, USA (May 16-18, 2023).

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK) today announced that the Investigational New Drug (IND) for a Phase I study of the first-in-class anti-CD24 monoclonal antibody ATG-031 has received clearance from the U.S. Food and Drug Administration (FDA).

Monogram Orthopaedics Inc. announced it raised $17,216,147 through the sale of 2,374,641 shares of its Class A Common Stock priced at $7.25 per share.

Biovica announces that Biovica Inc, the US laboratory and subsidiary of Biovica International AB, has signed a provider contract with MediNcrease Health Plans, a US, national provider network and provider advocacy firm, to make Biovica’s blood test DiviTum® TKa available to the more than 15 million lives served by Clients and Payers of MediNcrease.

Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2023 Annual General Meeting of Stockholders on Friday, May 19, 2023, at 11:30 a.m. PT.